{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:35:49Z","timestamp":1792060549302,"version":"4.4.0"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01055","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T01:00:58Z","timestamp":1592269258000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":87,"title":["Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity"],"prefix":"10.3389","volume":"11","author":[{"given":"Abdullah M.","family":"Izmirly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana O.","family":"Alturki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan O.","family":"Alturki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias K.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.ijid.2019.01.010","article-title":"Economic burden of dengue illness in India from 2013 to 2016: A systematic analysis","author":"Hariharan","year":"2019","journal-title":"Int J Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"Simmons","year":"2012","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.4049\/jimmunol.176.5.2825","article-title":"The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection","volume":"176","author":"Huang","year":"2006","journal-title":"J Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv Virus Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00018-010-0357-z","article-title":"Dengue virus life cycle: viral and host factors modulating infectivity","volume":"67","author":"Rodenhuis-Zybert","year":"2010","journal-title":"Cell Mol Life Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1086\/518007","article-title":"Dengue virus infects macrophages and dendritic cells in a mouse model of infection","volume":"195","author":"Kyle","year":"2007","journal-title":"J Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41577-019-0123-x","article-title":"Adaptive immune responses to primary and secondary dengue virus infections","volume":"19","author":"John","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/vaccines7040145","article-title":"The interplay between dengue virus and the human innate immune system: a game of hide and seek","volume":"7","author":"Tremblay","year":"2019","journal-title":"Vaccines."},{"key":"B10","doi-asserted-by":"publisher","first-page":"197770","DOI":"10.1016\/j.virusres.2019.197770","article-title":"Flavivirus Infection-A review of immunopathogenesis, immunological response, and immunodiagnosis","volume":"274","author":"Chong","year":"2019","journal-title":"Virus Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/oxfordjournals.bmb.a011708","article-title":"Molecular epidemiology and evolution of emerging infectious diseases","volume":"54","author":"Holmes","year":"1998","journal-title":"Br Med Bull."},{"key":"B12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.vaccine.2013.11.020","article-title":"Potential opportunities and perils of imperfect dengue vaccines","volume":"32","author":"Rodriguez-Barraquer","year":"2014","journal-title":"Vaccine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1099\/vir.0.2008\/002535-0","article-title":"Functional importance of dengue virus maturation: infectious properties of immature virions","volume":"89","author":"Zybert","year":"2008","journal-title":"J Gen Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12879-014-0570-8","article-title":"Dengue NS1 antigen as a marker of severe clinical disease","volume":"14","author":"Paranavitane","year":"2014","journal-title":"BMC Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1007625","DOI":"10.1371\/journal.ppat.1007625","article-title":"Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage","volume":"15","author":"Chao","year":"2019","journal-title":"PLoS Pathog."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4049\/jimmunol.166.3.1499","article-title":"Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production","volume":"166","author":"Ho","year":"2001","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.4049\/jimmunol.174.12.8163","article-title":"Dengue virus type 2 antagonizes IFN-\u03b1 but not IFN-\u03b3 antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell","volume":"174","author":"Ho","year":"2005","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1002934","DOI":"10.1371\/journal.ppat.1002934","article-title":"DENV inhibits type I IFN production in infected cells by cleaving human STING","volume":"8","author":"Aguirre","year":"2012","journal-title":"PLoS Pathog."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","article-title":"Inhibition of alpha\/beta interferon signaling by the NS4B protein of flaviviruses","volume":"79","author":"Munoz-Jord\u00e1n","year":"2005","journal-title":"J Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e926","DOI":"10.1371\/journal.pntd.0000926","article-title":"RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection","volume":"5","author":"Nasirudeen","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.chom.2012.04.006","article-title":"The mitochondrial targeting chaperone 14\u20133-3\u03b5 regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity","volume":"11","author":"Liu","year":"2012","journal-title":"Cell Host Microbe."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1128\/JVI.00221-16","article-title":"Dengue virus subverts host innate immunity by targeting adaptor protein MAVS","volume":"90","author":"He","year":"2016","journal-title":"J Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"13486","DOI":"10.1128\/JVI.01104-12","article-title":"Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells","volume":"86","author":"Schnettler","year":"2012","journal-title":"J Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.1128\/JVI.02774-12","article-title":"Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor","volume":"87","author":"Kakumani","year":"2013","journal-title":"J Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.cell.2018.11.028","article-title":"Comparative flavivirus-host protein interaction mapping reveals mechanisms of dengue and Zika virus pathogenesis","volume":"175","author":"Shah","year":"2018","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"9190","DOI":"10.1073\/pnas.1105079108","article-title":"Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance","volume":"108","author":"John","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1172\/JCI118964","article-title":"Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1","volume":"98","author":"Mathew","year":"1996","journal-title":"J Clin Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"eaal5088","DOI":"10.1126\/scitranslmed.aal5088","article-title":"Increased adaptive immune responses and proper feedback regulation protect against clinical dengue","volume":"9","author":"Simon-Loriere","year":"2017","journal-title":"Sci Transl Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"330ra36","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"Kirkpatrick","year":"2016","journal-title":"Sci Transl Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/14712598.2017.1356284","article-title":"Working towards dengue as a vaccine-preventable disease: challenges and opportunities","volume":"17","author":"Shrivastava","year":"2017","journal-title":"Exp Opin Biol Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2051013613507862","article-title":"Latest developments and future directions in dengue vaccines","volume":"2","author":"Thisyakorn","year":"2014","journal-title":"Ther Adv Vaccines."},{"key":"B34","unstructured":"World Health OrganizationInternational Travel and Health \u2013 Chapter 6. Vaccine-Preventable Diseases and Vaccines.2017"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1080\/21645515.2019.1658503","article-title":"A review of Dengvaxia(R): development to deployment","volume":"15","author":"Thomas","year":"2019","journal-title":"Hum Vaccin Immunother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1016\/j.vaccine.2015.05.059","article-title":"Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia","volume":"33","author":"Dorigatti","year":"2015","journal-title":"Vaccine."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1016\/j.vaccine.2015.09.108","article-title":"Development of the Sanofi Pasteur tetravalent dengue vaccine: one more step forward","volume":"33","author":"Guy","year":"2015","journal-title":"Vaccine."},{"key":"B38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0005584","DOI":"10.1371\/journal.pntd.0005584","article-title":"In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination","volume":"11","author":"Whitehead","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1473-3099(17)30166-4","article-title":"Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study","volume":"17","author":"S\u00e1ez-Llorens","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4269\/ajtmh.14-0625","article-title":"A phase II, randomized, safety and immunogenicity trial of a re-derived, live-attenuated dengue virus vaccine in healthy children and adults living in Puerto Rico","volume":"93","author":"Bauer","year":"2015","journal-title":"Am J Trop Med Hyg."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.4269\/ajtmh.16-0634","article-title":"Phase 1 randomized study of a tetravalent dengue purified inactivated vaccine in healthy adults in the United States","volume":"96","author":"Schmidt","year":"2017","journal-title":"Am J Trop Med Hyg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.vaccine.2010.11.050","article-title":"Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial","volume":"29","author":"Beckett","year":"2011","journal-title":"Vaccine."},{"key":"B44","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/infdis\/jiv082","article-title":"Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults","volume":"212","author":"Kirkpatrick","year":"2015","journal-title":"J Infect Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"7112","DOI":"10.1016\/j.vaccine.2015.11.022","article-title":"Development of a recombinant, chimeric tetravalent dengue vaccine candidate","volume":"33","author":"Osorio","year":"2015","journal-title":"Vaccine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.vaccine.2011.11.072","article-title":"Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice","volume":"30","author":"Brewoo","year":"2012","journal-title":"Vaccine."},{"key":"B47","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.1016\/j.vaccine.2011.07.020","article-title":"Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever","volume":"29","author":"Osorio","year":"2011","journal-title":"Vaccine."},{"key":"B48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4269\/ajtmh.2012.12-0361","article-title":"A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults","volume":"88","author":"Thomas","year":"2013","journal-title":"Am J Trop Med Hyg."},{"key":"B49","doi-asserted-by":"publisher","first-page":"698","DOI":"10.4269\/ajtmh.14-0268","article-title":"An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques","volume":"92","author":"Fernandez","year":"2015","journal-title":"Am J Trop Med Hyg."},{"key":"B50","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants","volume":"4","author":"Flingai","year":"2013","journal-title":"Front Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1016\/j.vaccine.2015.09.102","article-title":"Nucleic acid (DNA) immunization as a platform for dengue vaccine development","volume":"33","author":"Porter","year":"2015","journal-title":"Vaccine."},{"key":"B52","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1016\/j.vaccine.2015.09.101","article-title":"Preclinical and clinical development of a dengue recombinant subunit vaccine","volume":"33","author":"Manoff","year":"2015","journal-title":"Vaccine."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.vaccine.2010.01.022","article-title":"Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys","volume":"28","author":"Clements","year":"2010","journal-title":"Vaccine."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1016\/j.vaccine.2015.06.067","article-title":"Preclinical development of a dengue tetravalent recombinant subunit vaccine: immunogenicity and protective efficacy in nonhuman primates","volume":"33","author":"Govindarajan","year":"2015","journal-title":"Vaccine."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1080\/21645515.2018.1546523","article-title":"Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-Na\u00efve adults","volume":"15","author":"Manoff","year":"2019","journal-title":"Hum Vaccin Immunother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.1016\/j.vaccine.2010.07.073","article-title":"Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses","volume":"28","author":"Brandler","year":"2010","journal-title":"Vaccine."},{"key":"B57","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/vaccines3030503","article-title":"Immunogenic subviral particles displaying domain III of dengue 2 envelope protein vectored by measles virus","volume":"3","author":"Harahap-Carrillo","year":"2015","journal-title":"Vaccines."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1128\/JVI.02298-12","article-title":"An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection","volume":"87","author":"White","year":"2013","journal-title":"J Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12951-017-0259-4","article-title":"Multi-walled carbon nanotubes functionalized with recombinant Dengue virus 3 envelope proteins induce significant and specific immune responses in mice","volume":"15","author":"Versiani","year":"2017","journal-title":"J Nanobiotechnol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"30648","DOI":"10.1038\/srep30648","article-title":"Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice","volume":"6","author":"Chiang","year":"2016","journal-title":"Sci Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.4049\/jimmunol.1600927","article-title":"A tetravalent formulation based on recombinant nucleocapsid-like particles from dengue viruses induces a functional immune response in mice and monkeys","volume":"197","author":"Gil","year":"2016","journal-title":"J Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0006191","DOI":"10.1371\/journal.pntd.0006191","article-title":"A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice","volume":"12","author":"Ramasamy","year":"2018","journal-title":"PLOS Negl Trop Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.3389\/fmicb.2017.02644","article-title":"Pichia pastoris-expressed bivalent virus-like particulate vaccine induces domain III-focused bivalent neutralizing antibodies without antibody-dependent enhancement in vivo","volume":"8","author":"Shukla","year":"2018","journal-title":"Front Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e01181","DOI":"10.1128\/JVI.01181-17","article-title":"An envelope-modified tetravalent dengue virus-like-particle vaccine has implications for flavivirus vaccine design","volume":"91","author":"Urakami","year":"2017","journal-title":"J Virol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4161\/hv.1.5.2221","article-title":"Yellow fever 17D vaccine safety and immunogenicity in the elderly","volume":"1","author":"Monath","year":"2005","journal-title":"Hum Vaccines."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1016\/j.celrep.2019.05.053","article-title":"Common genetic variations associated with the persistence of immunity following childhood immunization","volume":"27","author":"O'Connor","year":"2019","journal-title":"Cell Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e27753","DOI":"10.1371\/journal.pone.0027753","article-title":"Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study","volume":"6","author":"Roukens","year":"2011","journal-title":"PLoS ONE."},{"key":"B68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41541-019-0133-5","article-title":"Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination","volume":"4","author":"Bradt","year":"2019","journal-title":"NPJ Vaccines."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1172\/JCI75429","article-title":"Immune activation alters cellular and humoral responses to yellow fever 17D vaccine","volume":"124","author":"Muyanja","year":"2014","journal-title":"J Clin Invest."},{"key":"B70","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1038\/ncomms10369","article-title":"Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination","volume":"7","author":"Fourati","year":"2016","journal-title":"Nat Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1188","DOI":"10.1371\/annotation\/f585335f-ff77-40ae-a8b6-ad6019af31aa","article-title":"In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection","volume":"5","author":"de Alwis","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/088282403763635465","article-title":"Antibody-dependent enhancement of virus infection and disease","volume":"16","author":"Tirado","year":"2003","journal-title":"Viral Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/icb.1964.44","article-title":"Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls","volume":"42","author":"Hawkes","year":"1964","journal-title":"Aust J Exp Biol Med Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"S347","DOI":"10.1086\/520581","article-title":"Epitopes required for antibody-dependent enhancement of ebola virus infection","volume":"196","author":"Takada","year":"2007","journal-title":"J Infect Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1128\/JVI.69.4.2393-2400.1995","article-title":"Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection","volume":"69","author":"Lund","year":"1995","journal-title":"J Virol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1078\/0171-2985-00142","article-title":"Expression and function of C1q receptors and C1q binding proteins at the cell surface","volume":"205","author":"Ghiran","year":"2002","journal-title":"Immunobiology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.91.5.1932","article-title":"RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway","volume":"91","author":"Mason","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"key":"B79","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1099\/vir.0.82537-0","article-title":"Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells","volume":"88","author":"Chareonsirisuthigul","year":"2007","journal-title":"J Gen Virol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science."},{"key":"B81","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fcimb.2019.00200","article-title":"Molecular simulations reveal the role of antibody fine specificity and viral maturation state on antibody-dependent enhancement of infection in dengue virus","volume":"9","author":"Ripoll","year":"2019","journal-title":"Front Cell Infect Microbiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","article-title":"Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever","volume":"40","author":"Kliks","year":"1989","journal-title":"Am J Trop Med Hyg."},{"key":"B83","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4269\/ajtmh.1988.38.172","article-title":"A prospective study of dengue infections in Bangkok","volume":"38","author":"Burke","year":"1988","journal-title":"Am J Trop Med Hyg."},{"key":"B84","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand: I. The 1980 outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"7239347","DOI":"10.1155\/2019\/7239347","article-title":"Cross-reaction, enhancement, and neutralization activity of dengue virus antibodies against zika virus: a study in the mexican population","volume":"2019","author":"Montecillo-Aguado","year":"2019","journal-title":"J Immunol Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science."},{"key":"B87","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cmi.2017.11.004","article-title":"Adverse birth outcomes associated with Zika virus exposure during pregnancy in S\u00e3o Jos\u00e9 do Rio Preto, Brazil","volume":"24","author":"Nogueira","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"B88","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1073\/pnas.1522136113","article-title":"Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort","volume":"113","author":"Katzelnick","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0255-0857.148369","article-title":"Dengue vaccines: challenges, development, current status and prospects","volume":"33","author":"Ghosh","year":"2015","journal-title":"Indian J Med Microbiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"112746","DOI":"10.1016\/j.jim.2020.112746","article-title":"Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations","volume":"479","author":"Havenar-Daughton","year":"2020","journal-title":"J Immunol Methods"},{"key":"B91","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10875-016-0268-3","article-title":"Human circulating T follicular helper cell subsets in health and disease","volume":"36","author":"Ueno","year":"2016","journal-title":"J Clin Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/art.25032","article-title":"Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus","volume":"62","author":"Simpson","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B93","doi-asserted-by":"publisher","first-page":"176ra32","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+ CXCR3+ CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci Transl Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.immuni.2013.09.007","article-title":"Circulating precursor CCR7loPD-1hi CXCR5+ CD4+ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure","volume":"39","author":"He","year":"2013","journal-title":"Immunity."},{"key":"B95","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.it.2014.06.002","article-title":"Phenotype and functions of memory Tfh cells in human blood","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2011.01.009","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity."},{"key":"B97","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","article-title":"Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses","volume":"39","author":"Locci","year":"2013","journal-title":"Immunity."},{"key":"B98","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cell.2010.10.032","article-title":"Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter","volume":"143","author":"Victora","year":"2010","journal-title":"Cell."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/infdis\/jiy360","article-title":"Activation of peripheral T follicular helper cells during acute dengue virus infection","volume":"218","author":"Haltaufderhyde","year":"2018","journal-title":"J Infect Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1189\/jlb.1009696","article-title":"Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells","volume":"89","author":"Martinez-Navio","year":"2011","journal-title":"J Leuk Biol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10875-017-0433-3","article-title":"Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID): molecular pathogenesis and clinical manifestations","volume":"37","author":"Bradford","year":"2017","journal-title":"J Clin Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-08801-1","article-title":"Adenosine deaminase-1 delineates human follicular helper T cell function and is altered with HIV","volume":"10","author":"Tardif","year":"2019","journal-title":"Nat Commun."},{"key":"B103","doi-asserted-by":"publisher","first-page":"27944","DOI":"10.1038\/srep27944","article-title":"Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine","volume":"6","author":"Farooq","year":"2016","journal-title":"Sci Rep."},{"key":"B104","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.4049\/jimmunol.1600883","article-title":"Water-in-oil\u2013only adjuvants selectively promote T follicular helper cell polarization through a type I IFN and IL-6\u2013dependent pathway","volume":"197","author":"Riteau","year":"2016","journal-title":"J Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.4049\/jimmunol.1402071","article-title":"MF59 mediates its B cell adjuvanticity by promoting T follicular helper cells and thus germinal center responses in adult and early life","volume":"194","author":"Gavillet","year":"2015","journal-title":"J Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0088441","article-title":"T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS ONE."},{"key":"B108","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/cei.12162","article-title":"High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis","volume":"174","author":"Wang","year":"2013","journal-title":"Clin Exp Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e57820","DOI":"10.1371\/journal.pone.0057820","article-title":"Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17-and activated B-cells and correlates with progression","volume":"8","author":"Christensen","year":"2013","journal-title":"PLoS ONE."},{"key":"B110","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.20081886","article-title":"Follicular helper T cells are required for systemic autoimmunity","volume":"206","author":"Linterman","year":"2009","journal-title":"J Exp Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01055\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T01:01:01Z","timestamp":1592269261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01055\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":110,"alternative-id":["10.3389\/fimmu.2020.01055"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01055","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"article-number":"1055"}}